I have recently read “Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations by Hirsh and Bhatt.1 I chose to compare those lessons learned with a relevant chapter in the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy.2